The listed company Processa announced a strategic investment and plans to incorporate cryptocurrency into its corporate financial management strategy
ChainCatcher news, according to GlobeNewswire, Processa Pharmaceuticals (NASDAQ: PCSA) announced today that it has secured a strategic investment and plans to incorporate cryptocurrency into its corporate financial management strategy. The company has engaged LifeSci Capital as an advisor to assist in implementing the related strategies.
Processa stated that this decision aims to diversify its capital structure and enhance financial flexibility. The company will explore the use of blockchain assets to support its clinical development projects while strictly adhering to regulatory standards.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.







